E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
Bonilla C, Mason T, Long L, Ahaghotu C, Chen W, Zhao A, Coulibaly A, Bennett F, Aiken W, Tullock T, Coard K, Freeman V, Kittles RA.
Bonilla C, et al. Among authors: ahaghotu c.
Prostate. 2006 Apr 1;66(5):546-56. doi: 10.1002/pros.20374.
Prostate. 2006.
PMID: 16372334